D. Beyersdorff et al., MRI of the prostate after combined radiotherapy (interstitial with external beam irradiation): Histopathological correlation., ROFO-F RONT, 172(8), 2000, pp. 680-685
Citations number
20
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
Aim: To identify the MRI changes of the prostate after combined (high-dose
rate interstitial with external beam) radiotherapy for, localized prostate
cancer and to correlate the findings with histology in order to determine t
he Value of MR imaging in the follow-up of these patients. Material and met
hods: Twenty-three patients underwent MR imaging at 1.5 T between 6 and 24
months after completion of combined radiotherapy. The prostate was imaged w
ith axial and coronal T-2-weighted sequences and axial T-1-weighted sequenc
es before and after intravenous administration of Cd-DTPA. Quadrant or sext
ant biopsy was performed in all cases and three patients with proven persis
tence of the tumor underwent salvage prostatectomy. The MRI findings were c
ompared with the biopsy results or the large-area sections. Results: On T-2
-weighted images the fibrotically changed peripheral zone was hypointense w
hile persistent tumor tissue showed hyperintensity. Solid tumors were depic
ted when they had a diameter of 1 cm or more. Persistent tumors of the diff
use multifocal type escaped detection. Contrast-enhanced T-1-weighted imagi
ng yielded no additional information. The accuracy in detecting persistent
tumor was 74%. Conclusions: Histopathologic changes seen after combined rad
iotherapy correlate with the findings on T-2-weighted MR images. MR imaging
cannot replace follow-up by routine biopsy. Its only role is assessing loc
al operability in cases found to have increasing PSA levers during follow-u
p. Further studies are needed to determine the role of MR imaging in this p
atient population.